152 related articles for article (PubMed ID: 19631530)
1. Design, syntheses, and evaluation of Taspase1 inhibitors.
Lee JT; Chen DY; Yang Z; Ramos AD; Hsieh JJ; Bogyo M
Bioorg Med Chem Lett; 2009 Sep; 19(17):5086-90. PubMed ID: 19631530
[TBL] [Abstract][Full Text] [Related]
2. Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression.
Hsieh JJ; Cheng EH; Korsmeyer SJ
Cell; 2003 Oct; 115(3):293-303. PubMed ID: 14636557
[TBL] [Abstract][Full Text] [Related]
3. Development of small molecule inhibitors and probes of human SUMO deconjugating proteases.
Albrow VE; Ponder EL; Fasci D; Békés M; Deu E; Salvesen GS; Bogyo M
Chem Biol; 2011 Jun; 18(6):722-32. PubMed ID: 21700208
[TBL] [Abstract][Full Text] [Related]
4. Bioassays to monitor Taspase1 function for the identification of pharmacogenetic inhibitors.
Knauer SK; Fetz V; Rabenstein J; Friedl S; Hofmann B; Sabiani S; Schröder E; Kunst L; Proschak E; Thines E; Kindler T; Schneider G; Marschalek R; Stauber RH; Bier C
PLoS One; 2011; 6(5):e18253. PubMed ID: 21647428
[TBL] [Abstract][Full Text] [Related]
5. A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity.
Wolfe MS; Citron M; Diehl TS; Xia W; Donkor IO; Selkoe DJ
J Med Chem; 1998 Jan; 41(1):6-9. PubMed ID: 9438016
[No Abstract] [Full Text] [Related]
6. 3,4-Fused cyclohexyl sulfones as gamma-secretase inhibitors.
Shaw D; Best J; Dinnell K; Nadin A; Shearman M; Pattison C; Peachey J; Reilly M; Williams B; Wrigley J; Harrison T
Bioorg Med Chem Lett; 2006 Jun; 16(11):3073-7. PubMed ID: 16617016
[TBL] [Abstract][Full Text] [Related]
7. Aspartic vinyl sulfones: inhibitors of a caspase-3-dependent pathway.
Glória PM; Coutinho I; Gonçalves LM; Baptista C; Soares J; Newton AS; Moreira R; Saraiva L; Santos MM
Eur J Med Chem; 2011 Jun; 46(6):2141-6. PubMed ID: 21439692
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease.
Shao YM; Yang WB; Kuo TH; Tsai KC; Lin CH; Yang AS; Liang PH; Wong CH
Bioorg Med Chem; 2008 Apr; 16(8):4652-60. PubMed ID: 18329272
[TBL] [Abstract][Full Text] [Related]
9. Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis.
Dong Y; Van Tine BA; Oyama T; Wang PI; Cheng EH; Hsieh JJ
Cell Res; 2014 Nov; 24(11):1354-66. PubMed ID: 25267403
[TBL] [Abstract][Full Text] [Related]
10. Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead.
Yin Z; Patel SJ; Wang WL; Wang G; Chan WL; Rao KR; Alam J; Jeyaraj DA; Ngew X; Patel V; Beer D; Lim SP; Vasudevan SG; Keller TH
Bioorg Med Chem Lett; 2006 Jan; 16(1):36-9. PubMed ID: 16246553
[TBL] [Abstract][Full Text] [Related]
11. Difluoro ketone peptidomimetics suggest a large S1 pocket for Alzheimer's gamma-secretase: implications for inhibitor design.
Moore CL; Leatherwood DD; Diehl TS; Selkoe DJ; Wolfe MS
J Med Chem; 2000 Sep; 43(18):3434-42. PubMed ID: 10978191
[TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C).
Kam CM; Götz MG; Koot G; McGuire M; Thiele D; Hudig D; Powers JC
Arch Biochem Biophys; 2004 Jul; 427(2):123-34. PubMed ID: 15196986
[TBL] [Abstract][Full Text] [Related]
13. Novel peptidyl aryl vinyl sulfones as highly potent and selective inhibitors of cathepsins L and B.
Mendieta L; Picó A; Tarragó T; Teixidó M; Castillo M; Rafecas L; Moyano A; Giralt E
ChemMedChem; 2010 Sep; 5(9):1556-67. PubMed ID: 20652927
[TBL] [Abstract][Full Text] [Related]
14. Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfones.
Bandarage UK; Wang T; Come JH; Perola E; Wei Y; Rao BG
Bioorg Med Chem Lett; 2008 Jan; 18(1):44-8. PubMed ID: 18054488
[TBL] [Abstract][Full Text] [Related]
15. A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth.
Chen DY; Lee Y; Van Tine BA; Searleman AC; Westergard TD; Liu H; Tu HC; Takeda S; Dong Y; Piwnica-Worms DR; Oh KJ; Korsmeyer SJ; Hermone A; Gussio R; Shoemaker RH; Cheng EH; Hsieh JJ
Cancer Res; 2012 Feb; 72(3):736-46. PubMed ID: 22166309
[TBL] [Abstract][Full Text] [Related]
16. Identification of a new class of nonpeptidic inhibitors of cruzain.
Brak K; Doyle PS; McKerrow JH; Ellman JA
J Am Chem Soc; 2008 May; 130(20):6404-10. PubMed ID: 18435536
[TBL] [Abstract][Full Text] [Related]
17. A Bivalent Supramolecular GCP Ligand Enables Blocking of the Taspase1/Importin α Interaction.
Höing A; Zimmermann A; Moews L; Killa M; Heimann M; Hensel A; Voskuhl J; Knauer SK
ChemMedChem; 2022 Jan; 17(1):e202100640. PubMed ID: 34623765
[TBL] [Abstract][Full Text] [Related]
18. Cell-based analysis of structure-function activity of threonine aspartase 1.
Bier C; Knauer SK; Klapthor A; Schweitzer A; Rekik A; Krämer OH; Marschalek R; Stauber RH
J Biol Chem; 2011 Jan; 286(4):3007-17. PubMed ID: 21084304
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of human Taspase1, a crucial protease regulating the function of MLL.
Khan JA; Dunn BM; Tong L
Structure; 2005 Oct; 13(10):1443-52. PubMed ID: 16216576
[TBL] [Abstract][Full Text] [Related]
20. Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival.
Princiotta MF; Schubert U; Chen W; Bennink JR; Myung J; Crews CM; Yewdell JW
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):513-8. PubMed ID: 11149939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
